The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | J | Antiinfectives for systemic use | |
2 | J07 | Vaccines | |
3 | J07B | Viral vaccines | |
4 | J07BC | Hepatitis vaccines | |
5 | J07BC01 | Hepatitis B, purified antigen |
Active Ingredient | Description | |
---|---|---|
Hepatitis B, purified antigen |
Hepatitis B vaccine induces specific humoral antibodies against hepatitis B virus surface antigen (anti-HBsAg). Hepatitis B vaccine has been recognized as the first anti-cancer vaccine because it can prevent primary liver cancer. |
Title | Information Source | Document Type | |
---|---|---|---|
ENGERIX-B Suspension for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
FENDRIX Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
HBVAXPRO Suspension for injection | European Medicines Agency (EU) | MPI, EU: SmPC | |
HEPLISAV B Solution for injection in pre-filled syringe | European Medicines Agency (EU) | MPI, EU: SmPC | |
RECOMBIVAX HB Suspension for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.